EX-99.2 3 dex992.htm CRANE CO. QUARTERLY FINANCIAL DATA SUPPLEMENT Crane Co. Quarterly Financial Data Supplement

Exhibit 99.2

CRANE CO.

Income Statement Data

(in thousands, except per share data)

 

     Three Months Ended
March 31,
     
     2010     2009      

Net Sales:

      

Aerospace & Electronics

   $ 133,645      $ 151,947     

Engineered Materials

     53,755        38,152     

Merchandising Systems

     70,171        71,694     

Fluid Handling

     247,789        266,497     

Controls

     24,931        26,849     
                  

Total Net Sales

   $ 530,291      $ 555,139     
                  

Operating Profit:

      

Aerospace & Electronics

   $ 24,489      $ 17,233     

Engineered Materials

     8,540        1,487     

Merchandising Systems

     4,969        2,980     

Fluid Handling

     27,989        36,767     

Controls

     126        414     

Corporate

     (12,833     (20,997   *
                  

Total Operating Profit

     53,280        37,884     

Interest Income

     225        843     

Interest Expense

     (6,726     (6,770  

Miscellaneous- Net

     (21     1,711     
                  

Income Before Income Taxes

     46,758        33,668     

Provision for Income Taxes

     13,574        10,238     
                  

Net income before allocations to noncontrolling interests

     33,184        23,430     

Less: Noncontrolling interest in subsidiaries' earnings (losses)

     (50     119     
                  

Net income attributable to common shareholders

     33,234        23,311     
                  

Share Data:

      

Earnings per Diluted Share

   $ 0.56      $ 0.40     
                  

Average Diluted Shares Outstanding

     59,570        58,543     

Average Basic Shares Outstanding

     58,650        58,453     

Supplemental Data:

      

Cost of Sales

   $ 352,271      $ 382,010     

Selling, General & Administrative

     124,740        135,245     

Depreciation and Amortization **

     14,437        15,053     

Stock-Based Compensation Expense

     3,172        2,062     

 

* Includes a charge of $7.75 million related to the settlement of a lawsuit.

 

** Amount included within cost of sales and selling, general & administrative costs.


CRANE CO.

Condensed Balance Sheets

(in thousands)

 

     March 31,
2010
   December  31,
2009
     

ASSETS

     

Current Assets

     

Cash and Cash Equivalents

   $ 319,584    $ 372,714

Accounts Receivable, net

     311,914      282,463

Current Insurance Receivable - Asbestos

     35,300      35,300

Inventories, net

     296,708      284,552

Other Current Assets

     72,430      71,317
             

Total Current Assets

     1,035,936      1,046,346

Property, Plant and Equipment, net

     285,715      285,224

Long-Term Insurance Receivable - Asbestos

     200,184      213,004

Other Assets

     407,859      406,346

Goodwill

     774,556      761,978
             

Total Assets

   $ 2,704,250    $ 2,712,898
             

LIABILITIES AND EQUITY

     

Current Liabilities

     

Notes Payable and Current Maturities of Long-Term Debt

   $ 879    $ 1,078

Accounts Payable

     155,966      142,390

Current Asbestos Liability

     100,300      100,300

Accrued Liabilities

     209,627      218,864

Income Taxes

     4,300      4,150
             

Total Current Liabilities

     471,072      466,782

Long-Term Debt

     398,602      398,557

Long-Term Deferred Tax Liability

     29,272      29,578

Long-Term Asbestos Liability

     696,768      720,713

Other Liabilities

     201,660      203,566

Total Equity

     906,876      893,702
             

Total Liabilities and Equity

   $ 2,704,250    $ 2,712,898
             


CRANE CO.

Condensed Statements of Cash Flows

(in thousands)

 

     Three Months Ended
March 31
     
     2010     2009      

Operating Activities:

      

Net income attributable to common shareholders

   $ 33,234      $ 23,311     

Noncontrolling interest in subsidiaries’ earnings (losses)

     (50     119     
                  

Net income before allocations to noncontrolling interests

     33,184        23,430     

Depreciation and amortization

     14,437        15,053     

Stock-based compensation expense

     3,172        2,062     

Deferred income taxes

     6,682        8,694     

Cash used for operating working capital

     (31,687     (27,619  

Other

     2,155        (8,892  
                  

Subtotal

     27,943        12,728     

Asbestos related payments, net of insurance recoveries

     (11,125     2,656      *
                  

Total provided by operating activities

     16,818        15,384     
                  

Investing Activities:

      

Capital expenditures

     (4,119     (9,974  

Proceeds from disposition of capital assets

     —          1,703     

Payment for acquisition - net of cash acquired

     (51,167     —       
                  

Total used for investing activities

     (55,286     (8,271  
                  

Financing Activities:

      

Dividends paid

     (11,743     (11,688  

Stock options exercised - net of shares reacquired

     4,714        (637  

Excess tax benefit from stock-based compensation

     391        —       

Change in short-term debt

     (3,046     (9,316  
                  

Total used for financing activities

     (9,684     (21,641  
                  

Effect of exchange rate on cash and cash equivalents

     (4,978     (6,997  
                  

Decrease in cash and cash equivalents

     (53,130     (21,525  

Cash and cash equivalents at beginning of period

     372,714        231,840     
                  

Cash and cash equivalents at end of period

   $ 319,584      $ 210,315     
                  
* Includes a $14.5 million insurance settlement receipt from the Highlands Insurance Company.


CRANE CO.

Order Backlog

(in thousands)

 

     March 31,
2010
   December 31,
2009
   September 30
2009
   June 30,
2009
   March 31,
2009

Aerospace & Electronics

   $ 388,169    $ 351,004    $ 369,898    $ 383,335    $ 396,393

Engineered Materials

     14,810      12,070      8,454      9,135      6,924

Merchandising Systems

     21,947      23,522      23,574      19,955      18,822

Fluid Handling

     253,946      249,901      252,333      256,467      275,660

Controls

     26,910      27,958      27,292      28,026      26,667
                                  

Total Backlog

   $ 705,782    $ 664,455    $ 681,551    $ 696,918    $ 724,466
                                  


CRANE CO.

Non-GAAP Financial Measures

(in thousands)

 

     Three Months Ended
March 31,
        Percent Change
March 31, 2010
 
        
     2010     2009         Three Months  

INCOME ITEMS

        

Net Sales

   $ 530,291      $ 555,139        -4.5

Operating Profit

     53,280        37,884       
Special Items impacting Operating Profit:         

Lawsuit Settlement—Pre-Tax (a)

     —          7,750       

Restructuring Charges (Gains)- Pre-Tax

     135        (448    

Operating Profit before Special Items

   $ 53,415      $ 45,186        18.2
                    

Percentage of Sales

     10.1     8.1    

Net Income Attributable to Common Shareholders

   $ 33,234      $ 23,311       

Per Share

   $ 0.56      $ 0.40       

Special Items impacting Net Income Attributable to Common Shareholders:

        

Lawsuit Settlement—Net of Tax (a)

     —          5,038       

Per Share

     —        $ 0.09       

Restructuring Charges (Gains)—Net of Tax

     96        (291    

Per Share

   $ 0.00      $ (0.00    

Net Income Attributable To Common Shareholders Before Special Items

   $ 33,330      $ 28,058        18.8
                    

Per Share

   $ 0.56      $ 0.48        16.7

(a)    During the three months ended March 31, 2009, the Company recorded a charge for the settlement of a lawsuit.

       

     Three Months Ended
March 31,
           
     2010     2009            
CASH FLOW ITEMS         

Cash Provided from Operating Activities before Asbestos—Related Payments

   $ 27,943      $ 12,728       

Asbestos Related Payments, Net of Insurance Recoveries

     (11,125     2,656      *  
                    

Cash Provided from Operating Activities

     16,818        15,384       

Less: Capital Expenditures

     (4,119     (9,974    
                    

Free Cash Flow

   $ 12,699      $ 5,410       
                    

 

* Includes a $14.5 million insurance settlement receipt from the Highlands Insurance Company.

Certain non-GAAP measures have been provided to facilitate comparison with the prior year.

The Company reports its financial results in accordance with U.S. generally accepted accounting principles (GAAP). However, management believes that non-GAAP financial measures which exclude certain non-recurring items present additional useful comparisons between current results and results in prior operating periods, providing investors with a clearer view of the underlying trends of the business. Management also uses these non-GAAP financial measures in making financial, operating, planning and compensation decisions and in evaluating the Company’s performance. In addition, Free Cash Flow provides supplemental information to assist management and investors in analyzing the Company’s ability to generate positive cash flow. Non-GAAP financial measures, which may be inconsistent with similarly captioned measures presented by other companies, should be viewed in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP.